NASDAQ : AVAH
Aveanna Healthcare Holdings Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 13.11 USD (Nov 2, 2026, 1:58 PM EST) · Market cap 2.86B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.86B |
| Enterprise Value | 4.26B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 218.22M |
| Shares Outstanding | 218.22M |
| Shares Change (YoY) | +12.72% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 3.18% |
| Owned by Institutions (%) | 37.99% |
| Float | 104.42M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 10.64 |
| Forward PE | 15.13 |
| PS Ratio | 1.10 |
| Forward PS | 1.02 |
| PB Ratio | 9.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.08 |
| P/OCF Ratio | 17.02 |
| PEG Ratio | 0.71 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 15.50 |
| EV / Sales | 1.64 |
| EV / EBITDA | 13.68 |
| EV / EBIT | 14.18 |
| EV / FCF | 26.89 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.16 |
| Quick Ratio | 1.09 |
| Debt / Equity | 5.23 |
| Debt / EBITDA | 4.44 |
| Debt / FCF | 9.50 |
| Interest Coverage | 2.24 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 198.57% |
| Return on Assets (ROA) | 9.68% |
| Return on Invested Capital (ROIC) | 18.60% |
| Return on Capital Employed (ROCE) | 17.72% |
| Weighted Average Cost of Capital (WACC) | 12.23% |
| Revenue Per Employee | $73,319 |
| Profits Per Employee | $7,740 |
| Employee Count | 35,500 |
| Asset Turnover | 1.34 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -120.65M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +44.97% |
| 50-Day Moving Average | 13.10 |
| 200-Day Moving Average | 9.25 |
| Relative Strength Index (RSI) | 55.24 |
| Average Volume (20 Days) | 2,100,962 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.34M |
| Short Previous Month | 5.67M |
| Short % of Shares Out | 2.45% |
| Short % of Float | 5.11% |
| Short Ratio (days to cover) | 1.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.60B |
| Gross Profit | 833.88M |
| Operating Income | 300.41M |
| Pretax Income | 154.11M |
| Net Income | 274.76M |
| EBITDA | 311.23M |
| EBIT | 300.41M |
| Earnings Per Share (EPS) | $1.23 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 109.23M |
| Total Debt | 1.51B |
| Net Cash | -1.40B |
| Net Cash Per Share | -$6.40 |
| Equity (Book Value) | 288.01M |
| Book Value Per Share | 1.32 |
| Working Capital | 66.77M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 168.20M |
| Capital Expenditures | -9.82M |
| Depreciation & Amortization | 10.82M |
| Net Borrowing | -3.35M |
| Free Cash Flow | 158.38M |
| FCF Per Share | $0.73 |
Margins
| Measure | Value |
|---|
| Gross Margin | 32.04% |
| Operating Margin | 11.54% |
| Pretax Margin | 5.92% |
| Profit Margin | 10.56% |
| EBITDA Margin | 11.96% |
| EBIT Margin | 11.54% |
| FCF Margin | 6.09% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.72% |
| Shareholder Yield | -12.72% |
| Earnings Yield | 9.40% |
| FCF Yield | 5.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $15.05 |
| Price Target Difference | 14.71% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 8.05% |
| EPS Growth Forecast (3Y) | 18.86% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |